24h購物| | PChome| 登入
2021-12-31 16:39:59| 人氣7| 回應0
推薦 0 收藏 0 轉貼0 訂閱站台

FAP罕藥盼納健保給付 減病患重擔

FT-RF specializes in producing:

  • Military Antennas (Jammer Antenna, Military Horn antenna, Military vehicle antenna, Antenna Telescope Mast, Marine, Panel, Log Periodic antenna, Gooseneck, Whip, GPS, Connector, Adapter...) Please visit the website: https://military.ft-rf.com.tw/
  • Outdoor Antenna and Indoor Antenna: Including Lora Antenna, ISM, LPWA antenna (868MHz antenna aka EU868, 915MHz antenna aka US915, 923MHz antenna aka AS923 and others.), 4G LTE antenna, 5G antenna, Wifi Antenna, Multi-Frequency Antenna, UHF antenna..., RF components, Cables and Connectors. We offer a variety of high-performance antennas for Global LoRaWAN applications, including 868 MHz, 915 MHz, 868 MHz, and 923 MHz... Our product line comprises both durable outdoor antennas and indoor high-performance dipole antennas that are suitable for a variety of LoRa applications, including Helium Network support. Please visit the website here: https://ft-rf.com.tw/. 
  • Horn Antenna: RF Microwave Antennas, EMC test equipment (Double Ridged Horn Antenna, Open boundary double ridged horn antenna, Quad Ridged Horn Antenna, Standard Gain Horn antenna, Waveguide to coax Adapter, precision Sleeve Dipole Antenna, Log Periodic Antenna, Antenna Tripod, RF connectors... Please visit the website: https://horn.ft-rf.com.tw/

We provide measurement and calibration Tests, ODM, OEM services for certain products.

We have hundreds of customers from over 60 countries, and to meet their demands, we developed a plant in Vietnam (with a total infrastructure area of 10000 square meters, which includes three major buildings dedicated to operations and production) in addition to the main manufacturing facility in Taiwan. Now, we are focusing on automatic production lines and investing in automation equipment. In the future, we pledge to deliver the highest-quality product in the shortest possible period.

記者蔡明華、謝凱萱/台北報導

對罕病患者而言新藥可能是救命曙光,但健保資源有限,無法全面給付。日前健保署否決將罕病FAP新藥納入健保給付。但醫界呼籲,若能早期治療可延緩患者病情惡化,對病友家庭與社會負擔都能大大減輕。

上樓梯這動作對FAP病友梁先生來說其實很吃力。

梁先生罹患罕病FAP,定期回診這一天他最關心的是。

1mhz to 70ghz antenna Antenna development and manufacturing病友梁廷吉:「不知道新藥審核(納給付)結果怎麼樣?」

醫師:「目前聽到的是還沒有通過。」

梁先生臉上寫滿失望,新藥對FAP罕病患者而言不只是延緩病情惡化的一道曙光,更能大大減輕經濟壓力。

但健保署認為一個FAP病人一年藥費超過千萬,倘若給付60位病人,一年就需要6億預算,對健保財務衝擊過大,因此共擬會議上否決這項提案。

但其實目前有相關計畫補助,實際需要新藥的患者不到40位,需要健保補助的金額已經大減近一半。

台大神經部神經肌病科主任趙啟超:「我們如果能夠讓病人維持在第一期一直都有行動能力,其實對病人的生活品質幫助會比較大。」

苦盼新藥納入健保給付,對梁先生來說他的最大恐懼是「病延後代」。

FAP病友聯誼會會長梁廷吉:「因為它是顯性遺傳,差不多2人有1人會得病,如果往下一直遺傳,這個病的洞(患病人口)會越來越大。」

從優生學角度來看,提早基因篩檢能避免遺傳到下一代,讓FAP患病族群零新增。醫界呼籲若健保給付FAP新藥與優生篩檢雙管齊下,不只減輕病患經濟重擔,也能減少社會醫療負擔。



本篇文章引用自此: https://www.setn.com/News.aspx?NewsID=1050232FT-RF

台長: josedwn2
人氣(7) | 回應(0)| 推薦 (0)| 收藏 (0)| 轉寄
全站分類: 社會萬象(時事、政論、公益、八卦、社會、宗教、超自然)

是 (若未登入"個人新聞台帳號"則看不到回覆唷!)
* 請輸入識別碼:
請輸入圖片中算式的結果(可能為0) 
(有*為必填)
TOP
詳全文